We anticipate physicians to use nomograms to evaluate prognosis, combined with clinical variables such as calcitonin, CEA, or the latest research results such as tumor necrosis and high mitotic rate [20] and expect them to confirm the output of the tool. This evidence concerns the gene CEACAM5 and neoplasm.